Freenome, Inc. (FRNM)
10.57
+0.39
(+3.83%)
USD |
NASDAQ |
Nov 09, 16:00
10.78
+0.21
(+1.99%)
After-Hours: 20:00
Freenome Enterprise Value : 108.58M for Nov. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 09, 2026 | 108.58M |
| November 06, 2026 | 104.55M |
| November 05, 2026 | 107.54M |
| November 04, 2026 | 116.11M |
| November 03, 2026 | 117.86M |
| November 02, 2026 | 119.30M |
| October 30, 2026 | 128.28M |
| October 29, 2026 | 132.19M |
| October 28, 2026 | 138.18M |
| October 27, 2026 | 134.05M |
| October 26, 2026 | 130.75M |
| October 23, 2026 | 131.27M |
| October 22, 2026 | 134.67M |
| October 21, 2026 | 144.05M |
| October 20, 2026 | 144.57M |
| October 19, 2026 | 129.20M |
| October 16, 2026 | 120.75M |
| October 15, 2026 | 126.26M |
| October 14, 2026 | 125.28M |
| October 13, 2026 | 129.93M |
| October 12, 2026 | 135.91M |
| October 09, 2026 | 162.31M |
| October 08, 2026 | 162.62M |
| October 07, 2026 | 164.89M |
| October 06, 2026 | 168.29M |
| Date | Value |
|---|---|
| October 05, 2026 | 173.14M |
| October 02, 2026 | 167.88M |
| October 01, 2026 | 160.87M |
| September 30, 2026 | 162.00M |
| September 29, 2026 | 163.75M |
| September 28, 2026 | 166.54M |
| September 25, 2026 | 164.48M |
| September 24, 2026 | 164.68M |
| September 23, 2026 | 161.48M |
| September 22, 2026 | 169.27M |
| September 21, 2026 | 170.77M |
| September 18, 2026 | 176.03M |
| September 17, 2026 | 167.57M |
| September 16, 2026 | 151.48M |
| September 15, 2026 | 150.55M |
| September 14, 2026 | 153.85M |
| September 11, 2026 | 147.77M |
| September 10, 2026 | 152.10M |
| September 09, 2026 | 162.00M |
| September 08, 2026 | 164.48M |
| September 04, 2026 | 167.78M |
| September 03, 2026 | 173.86M |
| September 02, 2026 | 164.06M |
| September 01, 2026 | 156.84M |
| August 31, 2026 | 152.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intellia Therapeutics, Inc. | 1.455B |
| Twist Bioscience Corp. | 8.409B |
| Natera, Inc. | 45.39B |
| Veracyte, Inc. | 1.761B |
| CareDx, Inc. | 4.207B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1149M |
| Total Expenses (Quarterly) | 0.1149M |
| EPS Diluted (Quarterly) | -0.0111 |
| Earnings Yield | -0.66% |
| Normalized Earnings Yield | -0.6528 |